Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience. [electronic resource]
Producer: 20180524Description: 927-935 p. digitalISSN:- 1365-2893
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- administration & dosage
- Biomarkers
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- genetics
- Hepatitis C -- drug therapy
- Humans
- Liver Function Tests
- Male
- Middle Aged
- Myanmar
- Odds Ratio
- Sofosbuvir -- administration & dosage
- Sustained Virologic Response
- Treatment Outcome
- Viral Load
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.